https://www.indianpharmapost.com/bayers-investigational-mri-contrast-agent-gadoquatrane-meets-primary-and-main-secondary-endpoints-in-pivotal-phase-iii-studies-166482025-01-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/synaffix-and-mitsubishi-tanabe-pharma-ink-license-agreement-for-adc-technology-166492025-01-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/merieux-completes-acquisition-of-bureau-veritas-food-testing-activities-in-canada-and-us-166502025-01-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/zim-laboratories-and-neuraxpharm-granted-marketing-authorization-for-buprenorphine-sublingual-film-in-europe-166512025-01-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/windlas-biotechs-new-injectable-facility-receives-gmp-certification-166522025-01-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/carbogen-amcis-successfully-completed-swissmedic-inspection-of-its-vionnaz-facility-166532025-01-10T00:00:00+05:30always0.9